Published in Obstet Gynecol Clin North Am on September 01, 2011
Cluster analysis of midlife women's sleep-related symptoms: racial/ethnic differences. Menopause (2015) 1.39
Perimenopause as a neurological transition state. Nat Rev Endocrinol (2015) 1.14
Interaction between reproductive hormones and physiological sleep in women. J Clin Endocrinol Metab (2015) 0.82
Genetic polymorphisms in the aryl hydrocarbon receptor-signaling pathway and sleep disturbances in middle-aged women. Sleep Med (2013) 0.80
Sex differences in sleep: impact of biological sex and sex steroids. Philos Trans R Soc Lond B Biol Sci (2016) 0.79
Insomnia in women approaching menopause: Beyond perception. Psychoneuroendocrinology (2015) 0.79
Physical activity and sleep among midlife women with vasomotor symptoms. Menopause (2013) 0.79
Menopausal Symptoms and Their Management. Endocrinol Metab Clin North Am (2015) 0.77
Menopause in multiple sclerosis: therapeutic considerations. J Neurol (2013) 0.77
The Risk of Being Obese According to Short Sleep Duration Is Modulated after Menopause in Korean Women. Nutrients (2017) 0.75
Association of sleep disturbance and sexual function in postmenopausal women. Menopause (2017) 0.75
Effects of Yoga and Aerobic Exercise on Actigraphic Sleep Parameters in Menopausal Women with Hot Flashes. J Clin Sleep Med (2016) 0.75
Telephone-Based Cognitive Behavioral Therapy for Insomnia in Perimenopausal and Postmenopausal Women With Vasomotor Symptoms: A MsFLASH Randomized Clinical Trial. JAMA Intern Med (2016) 0.75
Sleep Disorders in Postmenopausal Women. J Sleep Disord Ther (2015) 0.75
Menopausal Symptoms and Sleep Quality During Menopausal Transition and Postmenopause. Chin Med J (Engl) (2016) 0.75
Perimenopause: From Research to Practice. J Womens Health (Larchmt) (2015) 0.75
Instruments to study sleep disorders in climacteric women. Sleep Sci (2016) 0.75
Effect of acupuncture and its influence on cerebral activity in perimenopausal insomniacs: study protocol for a randomized controlled trial. Trials (2017) 0.75
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med (1993) 35.93
Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev (2002) 10.36
Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep (2004) 10.08
Objectively measured sleep characteristics among early-middle-aged adults: the CARDIA study. Am J Epidemiol (2006) 7.49
Self-reported and measured sleep duration: how similar are they? Epidemiology (2008) 5.81
Deaths: final data for 2008. Natl Vital Stat Rep (2011) 5.31
Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause (2003) 3.57
Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol (2000) 3.51
The normal menopause transition. Maturitas (1992) 3.07
Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol (2007) 2.65
Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep (2003) 2.60
Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry (1979) 2.60
National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med (2005) 2.57
Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition. Menopause (2005) 2.50
Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep (2008) 2.37
Beyond frequency: who is most bothered by vasomotor symptoms? Menopause (2008) 2.35
Race and financial strain are independent correlates of sleep in midlife women: the SWAN sleep study. Sleep (2009) 2.13
Menopausal status and sleep-disordered breathing in the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med (2003) 1.85
Marital happiness and sleep disturbances in a multi-ethnic sample of middle-aged women. Behav Sleep Med (2009) 1.83
Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab (2004) 1.81
Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med (2005) 1.72
Mortality related to actigraphic long and short sleep. Sleep Med (2010) 1.49
Sex, steroids, and sleep: a review. Sleep (1999) 1.47
Assessing menstrual cycles with urinary hormone assays. Am J Physiol Endocrinol Metab (2002) 1.46
Evaluation and management of sleep disturbance during the menopause transition. Semin Reprod Med (2010) 1.39
Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA (2004) 1.37
Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep (2010) 1.26
Prevalence of sleep disturbance in a primarily urban Florida County. Soc Sci Med (1976) 1.26
Sex steroid hormone profiles are related to sleep measures from polysomnography and the Pittsburgh Sleep Quality Index. Sleep (2008) 1.24
Modeling women's health during the menopausal transition: a longitudinal analysis. Menopause (2007) 1.24
Psychometric evaluation of the Insomnia Symptom Questionnaire: a self-report measure to identify chronic insomnia. J Clin Sleep Med (2009) 1.22
Insomnia: an epidemiological survey. Clin Neuropharmacol (1985) 1.12
Marital/cohabitation status and history in relation to sleep in midlife women. Sleep (2010) 1.09
Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med (2005) 1.08
Are inflammatory and coagulation biomarkers related to sleep characteristics in mid-life women?: Study of Women's Health across the Nation sleep study. Sleep (2010) 1.07
Socioeconomic status as a correlate of sleep in African-American and Caucasian women. Ann N Y Acad Sci (1999) 1.05
Sleep in women across the life cycle from adulthood through menopause. Sleep Med Rev (2003) 1.02
Sleep, rhythms and women's mood. Part II. Menopause. Sleep Med Rev (2006) 0.94
The menopause and climacteric: endocrinologic basis and associated symptomatology. J Am Geriatr Soc (1982) 0.92
Sleep in peri-menopausal and post-menopausal women. Sleep Med Rev (1998) 0.91
Prevalence of insomnia and its relationship to menopausal status in middle-aged Korean women. Psychiatry Clin Neurosci (2005) 0.90
Estrogen replacement therapy and nocturnal periodic limb movements: a randomized controlled trial. Obstet Gynecol (2001) 0.82
Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial. JAMA (2011) 2.70
Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Arch Gen Psychiatry (2007) 2.50
Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health (2006) 2.47
Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause (2012) 2.36
Beyond frequency: who is most bothered by vasomotor symptoms? Menopause (2008) 2.35
Longitudinal follow-up of bipolar disorder in women with premenstrual exacerbation: findings from STEP-BD. Am J Psychiatry (2011) 2.06
Ovarian hormone fluctuation, neurosteroids, and HPA axis dysregulation in perimenopausal depression: a novel heuristic model. Am J Psychiatry (2015) 1.89
Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause (2014) 1.67
Effect of escitalopram on hot flash interference: a randomized, controlled trial. Fertil Steril (2012) 1.62
Physical activity and risk of vasomotor symptoms in women with and without a history of depression: results from the Harvard Study of Moods and Cycles. Menopause (2006) 1.49
Effects of escitalopram on menopause-specific quality of life and pain in healthy menopausal women with hot flashes: a randomized controlled trial. Maturitas (2012) 1.49
Mood symptoms after natural menopause and hysterectomy with and without bilateral oophorectomy among women in midlife. Obstet Gynecol (2012) 1.47
Efficacy of omega-3 for vasomotor symptoms treatment: a randomized controlled trial. Menopause (2014) 1.44
Efficacy of yoga for vasomotor symptoms: a randomized controlled trial. Menopause (2014) 1.44
Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial. Menopause (2015) 1.40
Gains in body fat and vasomotor symptom reporting over the menopausal transition: the study of women's health across the nation. Am J Epidemiol (2009) 1.36
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31
Menopause-associated symptoms and cognitive performance: results from the study of women's health across the nation. Am J Epidemiol (2010) 1.22
Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN). J Clin Endocrinol Metab (2012) 1.15
Vasomotor symptoms and insulin resistance in the study of women's health across the nation. J Clin Endocrinol Metab (2012) 1.13
Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol (2006) 1.09
Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. Menopause (2006) 1.07
Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network. Menopause (2012) 1.03
Vasomotor symptoms and lipid profiles in women transitioning through menopause. Obstet Gynecol (2012) 1.00
Gender differences in bipolar disorder: retrospective data from the first 500 STEP-BD participants. Bipolar Disord (2005) 0.98
A reproductive subtype of depression: conceptualizing models and moving toward etiology. Harv Rev Psychiatry (2009) 0.98
Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation. Obstet Gynecol Clin North Am (2011) 0.91
Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial. Menopause (2011) 0.90
Sexual function in nondepressed women using escitalopram for vasomotor symptoms: a randomized controlled trial. Obstet Gynecol (2012) 0.90
Diagnosis and management of mood disorders during the menopausal transition. Am J Med (2005) 0.88
Paroxetine versus placebo for women in midlife after hormone therapy discontinuation. Am J Med (2008) 0.86
Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study. Depress Anxiety (2012) 0.86
Relation of daily urinary hormone patterns to vasomotor symptoms in a racially/ethnically diverse sample of midlife women: study of women's health across the nation. Reprod Sci (2007) 0.85
Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus-infected women. Menopause (2014) 0.84
The impact of depot GnRH agonist on AMH levels in healthy reproductive-aged women. J Clin Endocrinol Metab (2013) 0.84
Eszopiclone treatment for insomnia: effect size comparisons in patients with primary insomnia and insomnia with medical and psychiatric comorbidity. Prim Care Companion CNS Disord (2012) 0.81
Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause. Menopause (2015) 0.80
Menopause and mood. Clin Obstet Gynecol (2004) 0.80
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society. Menopause (2015) 0.79
Effects of escitalopram on markers of bone turnover: a randomized clinical trial. J Clin Endocrinol Metab (2014) 0.78
Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial. Obstet Gynecol (2014) 0.78
Effect of medroxyprogesterone on depressive symptoms in depressed and nondepressed perimenopausal and postmenopausal women after discontinuation of transdermal estradiol therapy. Menopause (2012) 0.77
Efficacy of 17beta-estradiol on depression: is estrogen deficiency really necessary? J Clin Psychiatry (2002) 0.77
Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition. Maturitas (2013) 0.77
Association of past and recent major depression and menstrual characteristics in midlife: Study of Women's Health Across the Nation. Menopause (2012) 0.76
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol (2015) 0.76
Depressive symptoms across the menopause transition: findings from a large population-based cohort study. Menopause (2016) 0.76
Disparate rates of new-onset depression during the menopausal transition in 2 community-based populations: real, or really wrong? Am J Epidemiol (2013) 0.76
Symptom clusters among MsFLASH clinical trial participants. Menopause (2016) 0.76
Association of estradiol with sleep apnea in depressed perimenopausal and postmenopausal women: a preliminary study. Menopause (2016) 0.75
Antidepressant use after discontinuation of hormone therapy: what can one infer about post-hormone therapy depression? Menopause (2013) 0.75
Interpreting incidence of hospitalization for postpartum psychotic and bipolar episodes study. Arch Gen Psychiatry (2009) 0.75
Characterizing the trajectories of vasomotor symptoms across the menopausal transition. Menopause (2016) 0.75
Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictors. Psychosom Med (2015) 0.75
Vaginal microbiota and genitourinary menopausal symptoms: a cross-sectional analysis. Menopause (2017) 0.75
Introduction: women's mental health: new research findings. Harv Rev Psychiatry (2009) 0.75
Validity, cut-points, and minimally important differences for two hot flash-related daily interference scales. Menopause (2017) 0.75
Armodafinil for fatigue associated with menopause: an open-label trial. Menopause (2016) 0.75
Treatment of Premenstrual Breakthrough of Depression With Adjunctive Oral Contraceptive Pills Compared With Placebo. J Clin Psychopharmacol (2017) 0.75
To the Editor. Menopause (2020) 0.75
Use of antidepressants during perimenopause. Womens Health (Lond Engl) (2006) 0.75